Amerigen Pharmaceuticals recalls
FDA enforcement reports naming Amerigen Pharmaceuticals Inc. as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Feb 27, 2019
- Feb 27, 2019Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-cou…Drug · Amerigen Pharmaceuticals Inc.Failed dissolution specificationsClass III
- Jan 2, 2019Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 cou…Drug · Amerigen Pharmaceuticals Inc.Failed Dissolution SpecificationsClass III
- Jan 2, 2019Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason…Drug · Amerigen Pharmaceuticals Inc.Failed Dissolution SpecificationsClass III
- Oct 24, 2018Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-co…Drug · Amerigen Pharmaceuticals Inc.Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.Class III